Basch Ethan, Iasonos Alexia, Barz Allison, Culkin Ann, Kris Mark G, Artz David, Fearn Paul, Speakman John, Farquhar Rena, Scher Howard I, McCabe Mary, Schrag Deborah
Department of Epidemiology and Biostatistics, and the Office of the Physician-in-Chief, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
J Clin Oncol. 2007 Dec 1;25(34):5374-80. doi: 10.1200/JCO.2007.11.2243.
In cancer treatment trials, clinicians traditionally report patient toxicity symptoms. Alternatively, patients could provide this information directly.
The Common Terminology Criteria for Adverse Events (CTCAE) is the mandated instrument for tracking patient toxicity symptoms in National Cancer Institute (NCI)-sponsored cancer treatment trials. We adapted CTCAE symptom items into patient language and uploaded these to an online platform. Lung cancer outpatients receiving chemotherapy were invited to self-report selected symptoms at visits via waiting area computers or optional home access. Symptom reports were printed for nurses at visits, but no instructions were given with regard to use of this information.
From June 2005 through March 2006, 125 patients were invited to participate, and 107 chose to enroll. Mean length of participation was 42 weeks (range, 1 to 71 weeks), by which time 35% died. The average number of clinic visits was 12 (range, 1 to 40 visits). At each consecutive visit, most patients (mean, 78%) logged in without significant attrition. Reasons for failure to log in included having no reminder and having inadequate time. Although 76% of enrollees had home computers, only 15% self-reported from home. Satisfaction with the system was high (90%), but only 51% felt communication was improved. All participating nurses understood the reports and felt this information was useful for clinical decisions, documentation, and discussions. However, only one of seven nurses discussed reports with patients frequently, with insufficient time being the most common barrier to discussions.
Online patient self-reporting is a feasible long-term strategy for toxicity symptom monitoring during chemotherapy, even among patients with advanced cancer and high symptom burdens. However, without explicit reminders and clinician feedback, patients demonstrated limited voluntary interest in self-reporting between visits.
在癌症治疗试验中,临床医生传统上会报告患者的毒性症状。或者,患者也可以直接提供此信息。
不良事件通用术语标准(CTCAE)是美国国立癌症研究所(NCI)资助的癌症治疗试验中用于追踪患者毒性症状的指定工具。我们将CTCAE症状条目改编成患者易懂的语言,并上传至在线平台。邀请接受化疗的肺癌门诊患者在就诊时通过候诊区的电脑或可选的家庭访问方式自行报告选定的症状。就诊时会为护士打印症状报告,但未就如何使用这些信息给出指示。
从2005年6月至2006年3月,邀请了125名患者参与,107名患者选择登记。平均参与时长为42周(范围为1至71周),此时35%的患者死亡。平均门诊就诊次数为12次(范围为1至40次)。在每次连续就诊时,大多数患者(平均78%)登录系统,且流失率不高。未登录的原因包括没有提醒以及时间不足。尽管76%的登记者家中有电脑,但只有15%的患者在家中自行报告。患者对该系统的满意度较高(90%),但只有51%的患者认为沟通得到了改善。所有参与的护士都理解这些报告,并认为这些信息对临床决策、记录和讨论有用。然而,七名护士中只有一名经常与患者讨论报告,时间不足是讨论的最常见障碍。
在线患者自我报告是化疗期间毒性症状监测的一种可行的长期策略,即使在晚期癌症和症状负担较重的患者中也是如此。然而,在没有明确提醒和临床医生反馈的情况下,患者在就诊期间自行报告的自愿性兴趣有限。